58 filings
8-K
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
8-K
MIRM
Mirum Pharmaceuticals Inc
28 Feb 24
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
4:05pm
8-K
MIRM
Mirum Pharmaceuticals Inc
16 Jan 24
Departure of Directors or Certain Officers
4:15pm
8-K
MIRM
Mirum Pharmaceuticals Inc
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
8-K
MIRM
Mirum Pharmaceuticals Inc
18 Dec 23
Other Events
4:06pm
8-K
qa8 jhh5y0m
2 Nov 23
Results of Operations and Financial Condition
4:06pm
8-K/A
x7tzihxbe1djbj 4tdu
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K
ag73 lbkt
17 Oct 23
Other Events
4:39pm
8-K
ddmwu 77ei5alybo
13 Oct 23
Other Events
4:16pm
8-K
0uu4q4ont78
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
8-K
kzqx6 25g4n9s2o
5 Sep 23
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
8:36am
8-K
abd mzqvwjcd
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
w4q82srd4qw
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
dlrm9ri
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
mv5t8j8x
13 Jun 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
mfbvbrx yy142zey0
4 May 23
Results of Operations and Financial Condition
4:02pm
8-K
7wvshsjp
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
8-K
oey2nki u41aw162wkb
12 Apr 23
Mirum Pharmaceuticals Announces Preliminary Unaudited First Quarter 2023 Financial Results
6:54am
8-K
fwbyuyoxz7a
6 Apr 23
Departure of Directors or Certain Officers
7:31am
8-K
rdk4if
10 Mar 23
Other Events
5:29pm